Ligand validation:6HXK

FLC: CITRATE ANION

FLC is a Ligand Of Interest in 6HXK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HXK_FLC_A_1200	49%	34%	0.152	0.897	1.04	1.54	-	3	0	0	100%	0.63
6HXK_FLC_C_1202	44%	36%	0.17	0.897	0.99	1.53	-	3	0	0	100%	1
6HXK_FLC_B_1201	24%	40%	0.195	0.825	1.02	1.29	1	3	0	0	100%	1
6HXK_FLC_D_1200	8%	24%	0.266	0.747	1.23	1.89	1	5	0	0	100%	0.39
6HXL_FLC_B_1202	96%	20%	0.066	0.973	0.98	2.38	-	5	0	0	100%	1
6HXM_FLC_A_1201	93%	24%	0.062	0.957	1.19	1.89	1	4	1	0	100%	1
2FT3_FLC_D_2193	100%	17%	0.024	0.996	1.26	2.29	-	6	5	0	100%	1
1YTA_FLC_D_1004	100%	5%	0.024	0.994	4.12	1.41	7	5	0	0	100%	1
3GNE_FLC_B_502	100%	32%	0.04	0.995	1.08	1.59	1	3	0	0	100%	1
4RX3_FLC_A_301	100%	29%	0.038	0.985	1.41	1.41	1	2	0	0	100%	1
4X84_FLC_C_300	100%	44%	0.045	0.985	1.36	0.81	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.